• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Glenmark Pharma makes entry into U.S. semisolid product market


Mumbai, India - Glenmark Pharmaceuticals, Inc., has begun U.S. marketing and distribution of five Clobetasol Propionate dermatology products, The Economy Times reports.

Mumbai, India

- A subsidiary of Glenmark Pharmaceuticals, Glenmark Pharmaceuticals, Inc., has begun marketing and distributing five Clobetasol Propionate dermatology products in the U.S., The Economy Times reports.

The products include cream, E-cream, ointment gel and topical solution and are being handled through a U.S.-based pharmaceutical development company, according to The Times.

The company plans to launch another 11 products throughout the course of a year.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.